Punyawudho B.; Lertdumrongluk P.; Somparn P.; Kittanamongkolchai W.; Traitanon O.; Avihingsanon Y.; Vadcharavivad S.
(2012)
Objective: Mycophenolic acid (MPA) has become the first-line drug therapy for proliferative lupus nephritis, a common and serious complication of systemic lupus erythematosus. Although a sufficient MPA exposure is required, ...